Illumination of a Vision 2020-Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions-Dream or Nightmare?

Thorsten H Ecke¹, Thomas Otto^{2

3}

Affiliations

¹ Department of Urology, HELIOS Hospital Bad Saarow, D-15526 Bad Saarow, Germany.
² Department of Urology, Lukaskrankenhaus Neuss, D-41464 Neuss, Germany.
³ University Hospital Essen, D-45147 Essen, Germany.

Editorial

Thorsten H Ecke et al. Int J Mol Sci. 2020.

. 2020 Mar 2;21(5):1694.

doi: 10.3390/ijms21051694.

Thorsten H Ecke¹, Thomas Otto^{2

3}

¹ Department of Urology, HELIOS Hospital Bad Saarow, D-15526 Bad Saarow, Germany.
² Department of Urology, Lukaskrankenhaus Neuss, D-41464 Neuss, Germany.
³ University Hospital Essen, D-45147 Essen, Germany.

Abstract

Bladder cancer is one of the most frequent malignancies worldwide [...].

1. Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., Forman D., Bray F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur. J. Cancer. 2013;49:1374–1403. doi: 10.1016/j.ejca.2012.12.027. - DOI - PubMed
1. Theodorescu D., Wittke S., Ross M.M., Walden M., Conaway M., Just I., Mischak H., Frierson H.F. Discovery and validation of new protein biomarkers for urothelial cancer: A prospective analysis. Lancet Oncol. 2006;7:230–240. doi: 10.1016/S1470-2045(06)70584-8. - DOI - PubMed
1. Sanchez-Carbayo M., Cordon-Cardo C. Molecular alterations associated with bladder cancer progression. Semin. Oncol. 2007;34:75–84. doi: 10.1053/j.seminoncol.2006.12.013. - DOI - PubMed
1. Mhawech-Fauceglia P., Cheney R.T., Schwaller J. Genetic alterations in urothelial bladder carcinoma: An updated review. Cancer. 2006;106:1205–1216. doi: 10.1002/cncr.21743. - DOI - PubMed
1. Botteman M.F., Pashos C.L., Redaelli A., Laskin B., Hauser R. The health economics of bladder cancer: A comprehensive review of the published literature. Pharmacoeconomics. 2003;21:1315–1330. doi: 10.1007/BF03262330. - DOI - PubMed